Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 144

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 144
---
, warranties, covenants or other agreements contained in the Divestiture Agreement; or                                                                                                                                         |

| • |     | prior to the approval of the Divestiture Agreement and the Divestiture by Aadi stockholders, if (1) Aadi has                                                                                                                               
 received a Superior Proposal; (2) Aadi’s board of directors has authorized Aadi to enter into an Alternative Acquisition Agreement to consummate the acquisition transaction contemplated by such Superior Proposal; (3) Aadi has complied 
 in all material respects with its covenants under the Divestiture Agreement with respect to such Superior Proposal; and (4) Aadi pays, or causes to be paid, to Kaken the termination fee prior to or concurrently with such termination.  |

In the event that the Divestiture Agreement is terminated pursuant to the termination rights above, the Divestiture Agreement will be of no further force or effect without liability of any party or its representatives to the other parties, as applicable, except certain sections of the Divestiture Agreement will survive the termination of the Divestiture Agreement, in each case in accordance with their respective terms. Notwithstanding the previous sentence, but subject to certain terms of the Divestiture Agreement, nothing in the Divesture Agreement will relieve any party from any liability for any material and willful breach of the Divestiture Agreement prior to the termination of the Divestiture Agreement. No termination of the Divestiture Agreement will affect the rights or obligations of any party pursuant to any confidentiality agreement, which will survive the termination of the Divestiture Agreement in accordance with its terms. Termination Fees and Remedies The Divestiture Agreement contains certain termination rights for Aadi and Kaken. Upon valid termination of the Divestiture Agreement under specified circumstances, Aadi has agreed to pay Kaken a one-time termination fee of $3.5 million. Specifically, this termination fee will be payable by Aadi to Kaken if any one of the following occur, under which circumstances the termination fee will be the sole and exclusive remedy of Kaken against Aadi for the termination of the Divestiture Agreement or the failure to complete the Divestiture:

| • |     | (1) the Divestiture Agreement is terminated because the completion of the Divestiture has not occurred by the                                                                                                                               
 Termination Date, or because of Aadi’s failure to obtain the required approval of Aadi stockholders; (2) at the time of such termination, certain of the closing conditions set forth in